Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture
Primary Purpose
Hip Fractures
Status
Terminated
Phase
Phase 4
Locations
Spain
Study Type
Interventional
Intervention
Supplement with HMB and vitamin D
Standard nutritional supplement
Sponsored by
About this trial
This is an interventional supportive care trial for Hip Fractures focused on measuring Hip fractures, Ageing, Sarcopenia, Function
Eligibility Criteria
Inclusion Criteria:
- Patients over 65 years of age after hip fracture surgery.
- Ability to walk before fracture.
Exclusion Criteria:
- Chronic renal failure, defined as a glomerular filtration rate less than 60 mL/min/1.73 m2, or serum creatinine of 0.9 mg/dL in women or 1.2 mg/dL in men.
- Following a diet with protein restriction.
- Need for enteral or parenteral nutrition.
- Need for medication with orexigenic or anabolic effect, or long-term corticosteroids.
- Active neoplastic disease.
- Cognitive impairment or major psychiatric disorder.
- Lack of signed informed consent.
- Any patient with inability to comply with treatment or not appropriate according to the investigator.
Sites / Locations
- Hospital Clinic de Barcelona
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Supplement with HMB and vitamin D
Standard nutritional supplement
Arm Description
Oral administration of 440 mL (2 bottles) of nutritional supplement with HMB and vitamin D each day during 8 weeks.
Oral administration of 440 mL (2 bottles) of standard nutritional supplement each day during 8 weeks.
Outcomes
Primary Outcome Measures
Change in bilateral knee extension test as a measure of isometric muscle strength.
Changes from baseline in the knee extension test at 8 weeks will be conducted using a dynamometer.
Secondary Outcome Measures
Change in the Timed Up & Go test as a measure of function.
Changes from baseline in the Timed Up & Go functional test at 8 weeks.
Full Information
NCT ID
NCT01850251
First Posted
May 3, 2013
Last Updated
August 18, 2015
Sponsor
Hospital Clinic of Barcelona
Collaborators
Abbott
1. Study Identification
Unique Protocol Identification Number
NCT01850251
Brief Title
Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture
Official Title
Randomized Controlled, Pilot Study to Assess the Effect of a High Protein and Calorie Nutritional Supplementation Enriched Hydroxymethylbutyrate and Vitamin D on Muscle Strength and Function in Patients With Hip Fracture.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2015
Overall Recruitment Status
Terminated
Why Stopped
Recruiting problems.
Study Start Date
June 2013 (undefined)
Primary Completion Date
March 2015 (Actual)
Study Completion Date
March 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Clinic of Barcelona
Collaborators
Abbott
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether a nutritional supplement high in protein and energy, and enriched with hydroxymethylbutyrate (HMB) and vitamin D is more effective than a standard nutritional supplement high in protein and energy in improving muscle strength in elderly patients with hip fracture.
Detailed Description
Hip fractures are the cause of substantial morbidity and mortality in elderly people. Nine months after hip fracture, patients still have a poorer quality of life compared to control subjects matched for age and sex.
After a hip fracture, many patients fail to return to their homes and their previous state of mobility. Acute hospital costs generated by this condition are substantial, although the costs in rehabilitation and special care in long-term community are even greater.
Patients with hip fracture are most likely to be frail elderly, and they are usually malnourished when the fracture occurs. Moreover, physiological aging is accompanied by functional losses and changes in the various organs and systems, including the musculoskeletal system, in which there is a progressive reduction of muscle mass, called sarcopenia. Approximately 30% of muscle mass is lost between the fifth and eighth decades of life and the percentage of muscle loss can reach 15% per decade after 70 years of age. Having established a correlation between the loss of muscle mass and loss of strength, sarcopenia has been associated with a risk of functional disability twice in men and thrice in women.
Hydroxymethylbutyrate (HMB) is a leucine metabolite produced in small quantities (0.3-0.4 g/d). Leucine effects on muscle metabolism appear to be due, in part, to HMB. In vitro experiments have observed that HMB attenuates proteolysis processes through the inhibition of various catabolic pathways and could stimulate protein synthesis. There are some evidences that administration of HMB in the elderly results in increases in muscle strength and functionality enhancements, compared to a control group.
In elderly people, low levels of vitamin D have been associated, among others, to decreased muscle strength, falls and fractures. The elderly have an increased risk of developing vitamin D deficiency due to less sun exposure, a decrease in the absorption and changes in the metabolism of this vitamin. Because muscle weakness is a clinical feature of vitamin D deficiency, it has been postulated that its deficiency could precipitate and increase muscle weakness and functional decline in older people.
Therefore, the study raises the possibility that an intervention consisting of a high protein, high calorie oral nutritional supplement enriched with HMB and vitamin D is more effective than a standard high protein, high calorie oral nutritional supplement in improving muscle strength.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Fractures
Keywords
Hip fractures, Ageing, Sarcopenia, Function
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Supplement with HMB and vitamin D
Arm Type
Experimental
Arm Description
Oral administration of 440 mL (2 bottles) of nutritional supplement with HMB and vitamin D each day during 8 weeks.
Arm Title
Standard nutritional supplement
Arm Type
Active Comparator
Arm Description
Oral administration of 440 mL (2 bottles) of standard nutritional supplement each day during 8 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Supplement with HMB and vitamin D
Other Intervention Name(s)
Ensure Plus Advance
Intervention Description
High protein, high calorie nutritional supplement enriched with hydroxymethylbutyrate and vitamin D.
Intervention Type
Dietary Supplement
Intervention Name(s)
Standard nutritional supplement
Other Intervention Name(s)
Ensure Plus High Protein
Intervention Description
High protein, high calorie nutritional supplement.
Primary Outcome Measure Information:
Title
Change in bilateral knee extension test as a measure of isometric muscle strength.
Description
Changes from baseline in the knee extension test at 8 weeks will be conducted using a dynamometer.
Time Frame
Baseline and 8 weeks
Secondary Outcome Measure Information:
Title
Change in the Timed Up & Go test as a measure of function.
Description
Changes from baseline in the Timed Up & Go functional test at 8 weeks.
Time Frame
Baseline and 8 weeks
Other Pre-specified Outcome Measures:
Title
Quality of life
Description
Change from baseline in quality of life at 8 weeks
Time Frame
Baseline and 8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients over 65 years of age after hip fracture surgery.
Ability to walk before fracture.
Exclusion Criteria:
Chronic renal failure, defined as a glomerular filtration rate less than 60 mL/min/1.73 m2, or serum creatinine of 0.9 mg/dL in women or 1.2 mg/dL in men.
Following a diet with protein restriction.
Need for enteral or parenteral nutrition.
Need for medication with orexigenic or anabolic effect, or long-term corticosteroids.
Active neoplastic disease.
Cognitive impairment or major psychiatric disorder.
Lack of signed informed consent.
Any patient with inability to comply with treatment or not appropriate according to the investigator.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maria T Forga, MD
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Joan Trabal, RD, MS
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Pere Leyes, MD
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Salvi Prat, MD, PhD
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Margarita Navarro, MD
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Study Chair
Facility Information:
Facility Name
Hospital Clinic de Barcelona
City
Barcelona
State/Province
Catalonia
ZIP/Postal Code
08036
Country
Spain
12. IPD Sharing Statement
Citations:
PubMed Identifier
21807930
Citation
Fuller JC Jr, Baier S, Flakoll P, Nissen SL, Abumrad NN, Rathmacher JA. Vitamin D status affects strength gains in older adults supplemented with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and lysine: a cohort study. JPEN J Parenter Enteral Nutr. 2011 Nov;35(6):757-62. doi: 10.1177/0148607111413903. Epub 2011 Aug 1.
Results Reference
background
Links:
URL
http://www.nhs.uk/Conditions/hip-fracture/Pages/introduction.aspx
Description
Click here for more information about hip fractures.
Learn more about this trial
Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip Fracture
We'll reach out to this number within 24 hrs